Reduced expression and content of glial-specific glutamine synthetase and glutamate transporter 1 (GLT1) has been observed in postmortem studies of patients with depression (Choudary et al., 2005), suggesting that glutamate clearance and metabolism are likely impaired in some brain regions. This evidence concerns the gene SLC1A2 and depressive symptom measurement.